Targeting nanoparticles rotate faster and move across larger areas
Targeted drug-delivery systems hold significant promise for treating cancer effectively by sparing healthy surrounding tissues. But the promising approach can only work if the drug hits its target.
A Northwestern University research team has developed a new way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended targets — by simply analyzing each nanoparticle’s distinct movements in real time.
By studying drug-loaded gold nanostars on cancer cell membranes, the researchers found that nanostars designed to target cancer biomarkers transited over larger areas and rotated much faster than their non-targeting counterparts. Even when surrounded by non-specifically adhered proteins, the targeting nanostars maintained their distinct, signature movements, suggesting that their targeting ability remains uninhibited.
“Moving forward, this information can be used to compare how different nanoparticle characteristics — such as particle size, shape and surface chemistry — can improve the design of nanoparticles as targeting, drug-delivery agents,” said Northwestern’s Teri Odom, who led the study.
The medical field has long been searching for alternatives to current cancer treatments, such as chemotherapy and radiation, which harm healthy tissues in addition to diseased cells. Although these are effective ways to treat cancer, they carry risks of painful or even dangerous side effects. By delivering drugs directly into the diseased area — instead of blasting the whole body with treatment — targeted delivery systems result in fewer side effects than current treatment methods.
“The selective delivery of therapeutic agents to cancer tumors is a major goal in medicine to avoid side effects,” Odom said. “Gold nanoparticles have emerged as promising drug-delivery vehicles that can be synthesized with designer characteristics for targeting cancer cells.”
Various proteins, however, tend to bind to nanoparticles when they enter the body. Researchers have worried that these proteins might impede the particles’ targeting abilities. Odom and her team’s new imaging platform can now screen engineered nanoparticles to determine if their targeting function is retained in the presence of the adhered proteins.
The Latest on: Drug-delivery nanoparticles
via Google News
The Latest on: Drug-delivery nanoparticles
- Aphios Granted US Patent For Combination HIV Latency Nanotherapeutic Towards an HIV Cureon January 28, 2020 at 8:24 am
Aphios granted US Patent for combination nanoparticle therapeutic for the treatment of HIV latency towards an HIV cure ...
- New Drug Delivery Systems Market And Top Key Players are 3M Company, Abbott Laboratories Ltd., Amgen Inc.on January 28, 2020 at 6:52 am
The following are the advantages related with nanoparticles as opposed to traditional drug delivery system - 1) Protects the drug from degrading in the body before reaching the target area 2) Easy ...
- Blood-triggered generation of platinum nanoparticle functions as an anti-cancer agenton January 28, 2020 at 2:17 am
Since the discovery of metal nanoparticles (NPs) in the 1960s, unknown toxicity ... These in vivo-generated metal NPs represent a biocompatible drug delivery platform for chemotherapy resistant tumor ...
- Novel Drug Delivery Systems Market Projected to Show Strong Growth | Amgen, Teva, Roche, Celgeneon January 27, 2020 at 6:43 am
Global Novel Drug Delivery Systems Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024 is latest research study released by HTF MI evaluating the market, highlighting ...
- New Drug Delivery Systems Market Trends, Outlook, Opportunity Till 2022on January 26, 2020 at 10:45 pm
Novel Drug Delivery System (NDDS) involves the prompt and efficient provision of the prescribed or therapeutic amount ...
- Nanoparticle Therapy Shows Promise with Breast Canceron January 24, 2020 at 5:55 am
The surface of the nanoparticles also was coated with polyethylene glycol to keep them circulating through the bloodstream and lymph system until they reached the tumor and to prevent them from being ...
- Aerosol-Assisted Synthesis of Tailor-Made Hollow Mesoporous Silica Microspheres for Controlled Release of Antibacterial and Anticancer Agents.on January 23, 2020 at 11:00 am
Hollow mesoporous silica microsphere (HMSM) particles are one of the most promising vehicles for efficient drug delivery owing to their large ... by continuous spray-drying of colloidal silica ...
- Science Revolution Sparked by Rapid Progress in Nanotechnologyon January 21, 2020 at 11:11 am
“It is crucial to increase the efficiency of drugs and to reduce side effects, and this is something that can be achieved with on-command drug delivery,” said Mr. Ohnoutek. “By illuminating metal ...
- Nano-silicon Drug Delivery Platform Market Worldwide Major Trend Outlook 2019 to 2027on January 17, 2020 at 2:23 am
Porous silicon nanoparticles are used in medical applications as drug delivery devices, owing to their high biocompatibility, surface area, and biodegradability. This has driven the nano-silicon drug ...
- Blood stem cell researchon January 15, 2020 at 5:11 pm
“We hope our nanoparticle delivery vehicles can enable the repair ... Hudson, an assistant professor in the College of Health Sciences, is working on drug delivery techniques using cell fragments.
via Bing News